|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:QuantaLife
gptkb:RainDance_Technologies
Celsee
|
|
gptkbp:CEO
|
gptkb:Norman_Schwartz
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:foundedYear
|
1952
|
|
gptkbp:founder
|
gptkb:David_Schwartz
gptkb:Alice_Schwartz
|
|
gptkbp:headquartersLocation
|
gptkb:Hercules,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bio-Rad
|
|
gptkbp:industry
|
gptkb:biotechnology
life sciences
clinical diagnostics
|
|
gptkbp:ISIN
|
US0905722072
|
|
gptkbp:market
|
global
|
|
gptkbp:notableProduct
|
immunoassay systems
PCR instruments
chromatography systems
electrophoresis apparatus
quality control products
|
|
gptkbp:numberOfEmployees
|
8000+
|
|
gptkbp:products
|
gptkb:software
laboratory instruments
reagents
consumables
|
|
gptkbp:publiclyTraded
|
true
|
|
gptkbp:revenue
|
$2.8 billion (2022)
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:BIO
|
|
gptkbp:subsidiary
|
gptkb:RainDance_Technologies
|
|
gptkbp:website
|
https://www.bio-rad.com/
|
|
gptkbp:bfsParent
|
gptkb:digital_PCR
|
|
gptkbp:bfsLayer
|
6
|